FMP
Jun 06, 2022(Last modified: Dec 19, 2023)
Oppenheimer analysts provided a review on Xylem Inc. (NYSE:XYL) following the investor meetings with CFO Sandy Rowland and VP of IR Andrea van der Berg.
The analysts come away incrementally constructive on the company's medium-term prospects, highlighting management’s commentary on underlying demand, with near-term revenue upside only limited by China lockdowns (approximately $40–50 million H1 impact) and well-documented chip shortages.
Adding strong price traction (particularly AWS), the analysts view the company's 2022 guidance framework as reasonable barring a significant shift in macro backdrop. Perhaps more importantly, management sounded confident in accelerating M&CS backlog conversion as chip supply improves and stressed the team's focus on strategic capital deployment/compound earnings growth.

In times of rising geopolitical tension or outright conflict, defense stocks often outperform the broader market as gove...

As Circle Internet (NYSE:CRCL) gains attention following its recent public listing, investors are increasingly scrutiniz...

LVMH Moët Hennessy Louis Vuitton (OTC:LVMUY) is a global leader in luxury goods, offering high-quality products across f...